Fetal Growth Restriction Perinatal Outcome Decision Support – improve perinatal outcomes in early-onset fetal growth restriction by rationalizing the decision of timing of delivery

FGR PODS aims to develop a decision support tool for obstetricians to optimize birth timing in early-onset fetal growth restriction, enhancing outcomes through data integration and machine learning analysis.

Subsidie
€ 2.000.000
2024

Projectdetails

Introduction

Early-onset foetal growth restriction <32 weeks’ gestation is a severe pregnancy disorder that affects an estimated 15,000 European pregnancies annually and puts the babies at risk of severe morbidity and mortality. The underlying mechanism of the disorder is placental insufficiency leading to failure to meet the foetal metabolic and respiratory demands (the first leading to the growth disorder, the latter leading to fetal demise).

Consequences of Early-Onset Foetal Growth Restriction

Birth of the foetus prevents further damage from the intrauterine environment but exposes the neonate to the challenges of severe prematurity. When women are admitted to the hospital with this complication of pregnancy, the obstetrician monitors the progressive signs of placental insufficiency and decides to expedite birth when the risks of foetal demise outweigh the risks of prematurity.

Current Challenges

Currently, there is lacking evidence on how to weigh all prognosticators in this balance; therefore, it takes place in the black box of the obstetrician's mind.

Project Overview: FGR PODS

In FGR PODS (Fetal Growth Restriction Perinatal Outcome Decision Support), I aim to develop and validate a ground-breaking decision support tool that will aid the obstetrician with objectively determining the optimal timing of birth.

Tool Features

The decision support tool will:

  • Integrate a combination of foetal and maternal prognosticators.
  • Be implemented in electronic patient charts.
  • Be provided as freeware.

Data Feedback and Continuous Improvement

Centres that have implemented the tool will feed back pseudonymized patient data in order to continuously refine the model.

Innovative Analysis

Also, within FGR PODS, I will perform innovative analysis (including machine learning) of fetal heart rate signals and of serially measured biomarkers to pick up placental respiratory failure. These studies will further our understanding of the foetal pathophysiological mechanisms resulting from placental insufficiency and will potentially identify targets for therapeutic interventions.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • STICHTING AMSTERDAM UMCpenvoerder
  • ACADEMISCH ZIEKENHUIS GRONINGEN
  • NEMO HEALTHCARE BV

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Impact of the embryonic obesogenic environment on programming of cardiovascular diseases across the life course

OBESE-EMBRYO aims to improve cardiovascular health in future generations by targeting the embryonic obesogenic environment in overweight and obese parents-to-be through innovative, evidence-based interventions.

€ 1.499.998
ERC Advanced...

Reprogramming of somatic cells into organOids: patient-centred neurodevelopmental disease modelling from nascent induced pluripotency

The project aims to develop a robust method for generating human brain organoids from patients with Fragile X Syndrome to explore neurodevelopmental phenotypes and inform targeted therapies.

€ 2.500.000
ERC Starting...

Pregnancy Dating Challenges: Technologies and Unequal Geographies of Abortion and Childbirth Care

PregDaT aims to critically analyze and transform pregnancy dating practices across Europe, highlighting socio-technical inequalities and reshaping policies for better reproductive care.

€ 1.497.984
ERC Proof of...

A tool to detect cognitive abnormalities in the first year of life based on electroencephalography (EEG)

The babylearn project aims to develop an EEG-based tool for early assessment of cognitive functions in infants, enhancing diagnosis and support for at-risk populations like premature babies.

€ 150.000
ERC Proof of...

Antagonizing GnRH signaling as a “holistic” therapeutic strategy for Polycystic Ovary Syndrome

GRASP aims to test low doses of a GnRH antagonist to reduce LH hyper-pulsatility and improve reproductive and metabolic traits in PCOS, paving the way for future clinical trials.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Artificial Placenta (ArtPlac) - Miniaturized Integrated Lung and Kidney Support for Critically Ill Newborns

The ArtPlac project aims to revolutionize newborn care by developing a compact artificial placenta to reduce neonatal deaths and long-term complications through less invasive support.

€ 4.229.608
EIC Pathfinder

Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain

Prometeus aims to personalize nutrition for premature neonates in NICUs through real-time adjustments of glucose and nutrients based on brain needs, reducing the risk of neurodevelopmental disabilities.

€ 3.554.156
EIC Accelerator

Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour cases

INNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval.

€ 2.342.835
EIC Pathfinder

PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal trauma

PELVITRACK aims to prevent pelvic floor disorders by developing a real-time monitoring solution for perineal tearing during vaginal deliveries through interdisciplinary research and innovative technologies.

€ 3.209.102
Mkb-innovati...

Early Moves at Home: a deployable and scalable service

Het project richt zich op het vroegtijdig diagnosticeren van ontwikkelingsstoornissen bij hoog-risico pasgeborenen thuis, om de ontwikkeling van kinderen te verbeteren en zorgkosten te verlagen.

€ 200.000